What's new with YKL-40?

Feb 04, 2009 - Researchers link YKL-40 plasma and tissue expression to ovarian cancer

YKL-40 protein expression was found in cancer cells, tumor associated macrophages, neutrophils and mast cells. The tumor cell expression was higher in OC than in borderline tumors (p = 0.001), and associated with FIGO stage (p < 0.0001) and histological subtype (p = 0.0009). Positive YKL-40 expression (? 5% staining) was not associated with reduced survival. Plasma YKL-40 was also higher in patients with OC than in patients with borderline tumors (p < 0.0001), and it was positively correlated to serum CA-125 (p < 0.0001) and FIGO stage (p = 0.0001). Univariate Cox analysis of plasma YKL-40 showed association with overall survival (p < 0.0001). Multivariate Cox analysis, including plasma YKL-40, serum CA125, FIGO stage, age and radicality after primary surgery as variables, showed that elevated plasma YKL-40 was associated with a shorter survival (HR = 2.13, 95% CI: 1.403.25, p = 0.0004).
Read Original Article

A-A+Font size    Print E-mail

News Archives

 

YKL-40 E-mail Updates

Periodically we send out e-mail updates about YKL-40. If you would like to receive these, please enter your e-mail address on the right.